Multiple Endocrine Neoplasia Type 1
Last Posted: Aug 13, 2020
- Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia.
Khairi Shafaq et al. Hormones & cancer 2020 Aug
- Inherited syndromes involving pancreatic neuroendocrine tumors.
Geurts Jennifer L et al. Journal of gastrointestinal oncology 2020 Jun 11(3) 559-566
- Health-related quality of life in patients with Multiple Endocrine Neoplasia type 1.
van Leeuwaarde Rachel S et al. Neuroendocrinology 2020 May
- Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variants.
Romanet Pauline et al. Human mutation 2019 40(6) 661-674
- Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Mulvey Claire K et al. Pancreas 2017 46(3) 416-426
- Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center.
Raue Friedhelm et al. The Journal of clinical endocrinology and metabolism 2019 May
- Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
Elisei Rossella et al. Annales d'endocrinologie 2019 Apr
- Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini Francesca et al. Orphanet journal of rare diseases 2018 13(1) 205
- Patient quality of life and prognosis in multiple endocrine neoplasia type 2.
Grey Joanna et al. Endocrine-related cancer 2018 25(2) T69-T77
- Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.
Castinetti Frederic et al. The lancet. Diabetes & endocrinology 2019 Jan
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.